These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4285635)

  • 21. Standardization of safety and potency tests of vaccines against poliomyelitis.
    Elisberg BL
    Rev Infect Dis; 1984; 6 Suppl 2():S519-22. PubMed ID: 6330850
    [No Abstract]   [Full Text] [Related]  

  • 22. THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS.
    VONKA V; JANDA Z; SIMON J
    Arch Gesamte Virusforsch; 1964 Jun; 14():599-610. PubMed ID: 14247356
    [No Abstract]   [Full Text] [Related]  

  • 23. Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand.
    Huang QS; Greening G; Baker MG; Grimwood K; Hewitt J; Hulston D; van Duin L; Fitzsimons A; Garrett N; Graham D; Lennon D; Shimizu H; Miyamura T; Pallansch MA
    Lancet; 2005 Jul 30-Aug 5; 366(9483):394-6. PubMed ID: 16054940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the viral RNA sequence heterogeneity for control of OPV neurovirulence.
    Chumakov K; Norwood L; Parker M; Dragunsky E; Taffs R; Ran Y; Ridge J; Levenbook I
    Dev Biol Stand; 1993; 78():79-89; discussion 88-9. PubMed ID: 8388834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excretion of attenuated polioviruses in children vaccinated with live oral poliovirus vaccine.
    Kucharská Z; Srámová H; Zdrazílek J
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(1):74-82. PubMed ID: 6282962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-poliomyelitis campaign in Taiwan.
    Hsu ST; Lin SY
    Southeast Asian J Trop Med Public Health; 1971 Jun; 2(2):140-6. PubMed ID: 4332824
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on safety tests of inactivated poliomyelitis vaccines. IV. Comparative safety tests in rhesus monkeys and long-tailed monkeys (Cercopithecus aethiops)].
    Günther O; Hövel H; von Mettenheim A; Burde K; Heber L; Unterharnscheidt F
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):137-50. PubMed ID: 4296870
    [No Abstract]   [Full Text] [Related]  

  • 28. Absence of wild poliovirus circulation among healthy children in a rural area with high oral poliovirus vaccination coverage.
    Deshpande JM; Rao VK; Karnataki MV; Nadkarni SS; Saxena VK; Karambelkar RR; Ramdasi SG; Patil KS; Rodrigues JJ
    Indian J Med Res; 1996 Jun; 103():289-93. PubMed ID: 8707367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New assays for the quality control of live oral poliovirus vaccine.
    Furesz J; Levenbook I
    Acta Microbiol Immunol Hung; 1998; 45(3-4):391-9. PubMed ID: 9873944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of type 3 poliovirus variants with increased L-cystine-dependence as live vaccines.
    Elbert LB; Chumakov MP; Krutyanskaya GL; Ralph NM; Tyufanov AV; Sokolova IS; Alpatova GA
    Arch Gesamte Virusforsch; 1971; 33(3):259-70. PubMed ID: 4329636
    [No Abstract]   [Full Text] [Related]  

  • 31. Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.
    Yang CF; Chen HY; Jorba J; Sun HC; Yang SJ; Lee HC; Huang YC; Lin TY; Chen PJ; Shimizu H; Nishimura Y; Utama A; Pallansch M; Miyamura T; Kew O; Yang JY
    J Virol; 2005 Oct; 79(20):12623-34. PubMed ID: 16188964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S
    J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Booster effect of oral poliovaccine. Trials in persons previously immunized with inactivated vaccine.
    McCollough RH; Glezen WP; Lamb GA; Chin TD
    Am J Dis Child; 1969 Feb; 117(2):161-8. PubMed ID: 4303394
    [No Abstract]   [Full Text] [Related]  

  • 34. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.
    Stenvik M; Hovi L; Siimes MA; Roivainen M; Hovi T
    Pediatr Infect Dis J; 1987 Dec; 6(12):1106-10. PubMed ID: 2829105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan.
    Yoshida H; Horie H; Matsuura K; Miyamura T
    Lancet; 2000 Oct; 356(9240):1461-3. PubMed ID: 11081527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What threat from persistent vaccine-related poliovirus?
    MacLennan C; MacLennan J
    Lancet; 2005 Jul 30-Aug 5; 366(9483):351-3. PubMed ID: 16054925
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental study on alimentary poliovirus infection and local immunity of intestines. II. Inhibitory effects of the circulating antibodies and coproantibody against the alimentary infection of Type I attenuated poliomyelitis virus.
    Ogawa M
    Sapporo Igaku Zasshi; 1965; 28(4):320-8. PubMed ID: 5895985
    [No Abstract]   [Full Text] [Related]  

  • 38. Intratypic serodifferentiation of polioviruses by comparison of neutralization indices and correlation of the antigenic marker, temperature marker and monkey neurovirulence.
    Smit GL; Wilterdink JB
    Arch Gesamte Virusforsch; 1966; 18(3):261-75. PubMed ID: 4295526
    [No Abstract]   [Full Text] [Related]  

  • 39. Excretion of live attenuated polioviruses in the faeces of orally vaccinated children. Comparison of two immunization schedules.
    Kucharská Z
    J Hyg Epidemiol Microbiol Immunol; 1985; 29(2):211-8. PubMed ID: 2991368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cells.
    Mallet L; Pelloquin F; Brigaud M; Caudrelier P; Bandet R; Xueref C; Fuchs F; Gibelin N; Goldman C; Moulin JC; de Fraipont F; Montagnon B; Peyron L; Aymard M
    J Med Virol; 1997 May; 52(1):50-60. PubMed ID: 9131458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.